Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Sangamo First Quarter 2023 Teleconference Call. At this time, all participants are in a listen-only mode.
Sangamo Therapeutics Inc (SGMO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rokos Capital Management Chris Rokos | 6,474,348 | $11,394,852 | +114% | 0.84% |
| 2. | Citadel Investment Group Ken Griffin | 3,233,150 | $5,690,344 | +131% | 0% |
| 3. | Avidity Partners Management David Witzke And Michael Gregory | 2,470,000 | $4,347,200 | -11% | 0.14% |
| 4. | D E Shaw D. E. Shaw | 1,793,187 | $3,156,009 | +31% | 0% |
| 5. | Hudson Bay Capital Management Sander Gerber | 1,200,000 | $2,112,000 | +4% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.69 | 6,784 | Director | 32,484 | 2022-06-03 | Filing | |
| $3.60 | 5,000 | Director | 48,700 | 2022-06-01 | Filing | |
| $5.20 | 3,000 | Director | 13,000 | 2020-03-18 | Filing | |
| $4.99 | 5,000 | Director | 30,000 | 2020-03-17 | Filing | |
| $5.67 | 5,000 | Director | 25,000 | 2020-03-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.27 | 100,000 | Large Shareholder | 23,652,466 | 2022-08-30 | Filing | |
| $5.33 | 400,000 | Large Shareholder | 23,752,466 | 2022-08-29 | Filing | |
| $8.51 | 2,764 | Large Shareholder | 24,152,466 | 2021-12-28 | Filing | |
| $8.56 | 600 | Large Shareholder | 24,155,230 | 2021-12-27 | Filing | |
| $8.55 | 81,187 | Large Shareholder | 24,155,830 | 2021-12-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 15,840,694 | $27,879,621 | 0% | |
| 2. | 14,380,909 | $25,310,400 | 0% | |
| 3. | 13,642,417 | $24,010,654 | 0.14% | |
| 4. | 8,960,578 | $15,770,617 | 0% | |
| 5. | 3,819,113 | $6,721,639 | 0% |
News See All
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q4 2022 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and thank you, for standing by. Welcome to the Sangamo Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
10 Best Gene Editing Stocks To Buy
A report by The Wall Street Journal dated September 16 suggests that Intellia Therapeutics, Inc.
Were Hedge Funds Right About Selling Sangamo Therapeutics, Inc. (SGMO)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Wasatch Global on Sangamo (SGMO): "We Remain Optimistic About its Future Prospects"
Wasatch Global Investors, an investment management firm, published its “Wasatch Ultra Growth Fund” first quarter 2021 investor letter – a copy of which can be downloaded here.
Is Sangamo Therapeutics (SGMO) Stock a Buy For 2021?
Wasatch Ultra Growth Fund recently released its Q4 2020 Investor Letter, a copy of which you can download here.
Is Sangamo Therapeutics, Inc. (SGMO) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Did Hedge Funds Make The Right Call On Sangamo Therapeutics, Inc. (SGMO) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Hedge Funds Are Getting Crazy About Sangamo Therapeutics, Inc. (SGMO)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.
Hedge Funds Are Dumping Sangamo Therapeutics, Inc. (SGMO)
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...
Billionaire Hedge Funds
